Search results for: 'active ingredients for cosmetics'
- Did you mean
- action ingredients for cosmetics
- Related search terms
- cosmetics AND stem cell conditined media And Beauty
- forging AND Casting
- forecasting the global imaging market for 2026
- forecasting the global imaging market for 2024®ions=235
- cosmetics ad system cell condition market ad beauty
-
06 Apr 2017  |  North America  |  Market Research
Growth Opportunities in the US Telehealth Market, Forecast to 2021
Healthcare Specialties such as Telebehavioral Health, Teledermatology, and Medical-grade Activity Tracking Expected to Add Value for both Patients and Physicians
Telehealth services and systems have made the most progress in remote management of post-acute care patients or among patients with chronic conditions, many of whom have one or more co-morbidity. This progress is visible across 4 major segments: remote patient monitoring (RPM), virtual telehealth visits, mobile health (mHealth), and personal emerge...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Jul 2021  |  North America  |  Market Research
Global Decentralized Clinical Trial (DCT) Growth Opportunities
Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum
Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (CR...
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Aug 2016  |  North America  |  Market Research
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...
$7,000.00
Special Price $5,250.00 save 25 %
-
13 Sep 2021  |  North America  |  Market Research
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Jul 2023  |  North America  |  Market Research
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Right Shoring and Targeted Therapeutics Create Future Growth
CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Feb 2003  |  North America  |  Market Research
U.S. Botulinum Toxin Emerging Markets
The U.S. Botulinum toxin emerging markets report provides revenue forecasts, market shares, patient and procedure forecasts, market and technology trends, and existing and emerging applications. The market is segmented by product application, namely cosmetic and therapeutic. Within these segments, emphasis is placed on comparing botulinum toxin to...
$2,450.00
Special Price $1,837.50 save 25 %
-
25 Sep 2004  |  North America  |  Market Research
U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)
Biomaterials derived from Hyaluronic Acid (HA) are extensively used in the healthcare industry. Their application ranges from treating osteoarthritis to enabling cataract surgeries to erasing facial wrinkles to preventing post-surgical adhesions. In spite of its wide use, the HA biomaterials market in the United States is not without its worries. ...
$2,450.00
Special Price $1,837.50 save 25 %
-
02 Dec 2019  |  North America  |  Market Research
Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024
Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment and Personalized Medicine, Will Give a New Growth Vector to CMOs
Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Aug 2019  |  North America  |  Market Research
Market Assessment of Global Refurbished Medical Imaging Equipment, Forecast to 2023
Quality Refurbishment Processes, Regulatory Relaxations, Persuasiveness of Circular Economy, and New Marketing Channels Fuel the Market Adoption of Refurbished Imaging Equipment
Advancements in medical imaging technology are serving to achieve state-of-the-art healthcare management across the globe. However, not all hospitals and independent diagnostic imaging centers have access to these advanced medical imaging equipment. This is mainly because of budget constraints and continuous consolidation of healthcare facilities. ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %